Wordt geladen...
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy
INTRODUCTION: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, and its pathogenesis is strictly related to altered cellular response to hypoxia, in which mTOR signaling pathway is implicated. Everolimus, an mTOR serine/threonine kinase inhibitor, represents a therapeuti...
Bewaard in:
| Gepubliceerd in: | Core Evid |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5012611/ https://ncbi.nlm.nih.gov/pubmed/27621699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S98687 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|